Background and purpose: Hepatic encephalopathy is a neuropsychiatric disorder of complex pathogenesis caused by acute or chronic liver failure. We investigated the effects of cannabidiol, a non-psychoactive constituent of Cannabis sativa with antiinflammatory properties that activates the 5-hydroxytryptamine receptor 5-HT 1A , on brain and liver functions in a model of hepatic encephalopathy associated with fulminant hepatic failure induced in mice by thioacetamide.
Introduction
Hepatic encephalopathy (HE) is a syndrome observed in patients with end-stage liver disease. It is defined as a spectrum of neuropsychiatric abnormalities in patients with liver dysfunction, after exclusion of other known brain diseases, and is characterized by personality changes, intellectual impairments, and a depressed level of consciousness associated with multiple neurotransmitter systems, astrocyte dysfunction and cerebral perfusion (Riggio et al., 2005; Avraham et al.,2006; 2008a ,2009 Magen et al.,2008; Butterworth, 2010) . Subtle signs of HE are observed in nearly 70% of patients with cirrhosis and approximately 30% of patients dying of end-stage liver disease experience significant encephalopathy (Ferenci,1995) . HE, accompanying the acute onset of severe hepatic dysfunction, is the hallmark of fulminant hepatic failure (FHF) and patients with HE have been reported to have elevated levels of ammonia in their blood (Stahl, 1963) . In addition, the infiltration of TNF-α-secreting monocytes into the brain of bile-duct ligated mice, a model of chronic liver disease, has been found 10 days after the ligation, indicating that neuroinflammation is involved in the pathogenesis of HE. This infiltration was shown to be associated with activation of the cerebral endothelium and an increase in the expression of adhesion molecules ( Κerfoot et al., 2006 ) . (Izzo et al., 2009) . Many mechanisms have been suggested for its action, such as agonism of 5-HT 1A receptors (Russo et al., 2005) . It also has a very strong anti-inflammatory activity both in vivo, as an anti-arthritic therapeutic (Malfait et al., 2000; Durst et al.,2007) , and in vitro, manifested by inhibition of cytokine production in immune cells (Ben Shabat et al., 2006) . The finding that CBD is devoid of any psychotrophic effects combined with its anti-inflammatory activity makes it a promising tool for treating HE, which is exacerbated by an inflammatory response (Shawcross et al., 2004) . In the present work, we aimed to explore the effects of CBD in the acute model of HE induced by the hepatotoxin thioacetamide (TAA), focusing on brain function, brain pathology and 5-HT levels, liver function and pathology as possible targets for therapeutic effects of CBD.
Cannabidiol (CBD) is a non-psychoactive ingredient of Cannabis sativa

Methods
Mice
Female Sabra mice (34-36g), 8 to 10 weeks old, were assigned at random to different groups of 10 mice per cage and were used in all experiments. All cages contained wood-chip bedding and were placed in a temperature-controlled room at 22°C, on a 12 h light/dark cycle (lights on at 07h00min). The mice had free access to water 24 h a day. The food provided was Purina chow and the animals were maintained in the animal facility (SPF unit) of the Hebrew University Hadassah Medical School, Jerusalem. Mice were killed after each treatment by decapitation between 10h00min and 12h00min. Animals were kept at the animal facility in accordance with NIH guidelines and all experiments were approved by the institutional animal use and care committee, No. MD -89.52-4.
Induction of hepatic failure
We adapted the rat model of acute liver failure induced by thioacetamide (TAA) to mice (Zimmermann et al ., 1989 ). The TAA model in mice has been extensively validated previously (Honda et al., 2002; Fernandez-Martinez A et al., 2004; Schnur et al., 2004) . TAA was obtained from Sigma-Aldrich (Rehovot, Israel) in powder form and dissolved in sterile normal saline solution (NS); it was injected i.p. as a single dose of 200mg kg -1 . Vehicle (NS) was also administered in a separate group of animals that served as controls. Twenty-four hours after injection of TAA all animals 6 (including control) were injected s.c. with 0.5 ml of a solution containing 0.45% NaCl, 5% dextrose and 0.2% KCl in order to prevent hypovolaemia, hypokalaemia and hypoglycaemia. The mice were intermittently exposed to infrared light in order to prevent hypothermia.
Administration of CBD
CBD was extracted from cannabis resin (hashish) and purified as previously reported (Gaoni et al.,1971) and was dissolved in a vehicle solution consisting of ethanol, emulphor and saline at a ratio of 1:1:18, respectively, and was injected in a single dose of 5mg kg -1 i.p, one day after either NS or TAA treatment. Similarly, the CBD related vehicle (the same mixture without CBD) was administered at the same time points following either NS or TAA treatment. A dose of 5mg kg -1 cannabidiol was chosen based on the studies done by Magen et al. (2009 Magen et al. ( , 2010 and on preliminary experiments done in our laboratory, which demonstrated that this does produced a maximal effect compared to 1 and 10mg kg -1 . Four groups of animals were studied: control naïve animals treated with either CBD or its vehicle, and corresponding TAA-treated animals.
Assessment of neurological function
Neurological function was assessed by a 10 point scale based on reflexes and task performance (Chen et al., 1996) : exit from a 1 metre in diameter circle in less than 1 min, seeking, walking a straight line, startle reflex, grasping reflex, righting reflex, placing reflex, corneal reflex, maintaining balance on a beam 3, 2 and 1 cm in width, climbing onto a square and a round pole. For each task failed or abnormal reflex reaction a score of 1 was assigned. Thus, a higher score indicates poorer neurological function. The neurological score was assessed one day after induction of hepatic failure by TAA (day 2). The mice were then divided between treatment groups so that all groups had similar baseline neurological scores after TAA induction. The post-7 treatment neurological score was assessed one day after administration of CBD or vehicle (day 3).
Assessment of activity
The activity test was performed two days after the induction of hepatic failure.
Activity of two mice was measured simultaneously for a 5 min period. Two mice were tested together to lower stress to the minimum, as it has been shown that separation of mice induces stress (van Leeuwen et al.,1997; Hao et al.,2001) . Activity was assessed in the open field (20x30cm field divided into 12 squares of equal size)
as described previously (Fride and Mechoulam., 1993) . Locomotor activity was recorded by counting the number of crossings by the mice at 1 min intervals.
Results are presented as the mean number of crossings min -1 .
Cognitive function
Cognitive function studies were performed eight days after the induction of hepatic failure. The animals were placed in an eight arm maze, which is a scaled-down version of that developed for rats (Pick and Yanai, 1983,) . Mice were deprived of water 2 h prior to the test and a reward of 50µl of water was presented at the end of each arm, in order to motivate them to perform the task. Animals were divided between treatment groups so that all groups had similar baselines neurological scores after TAA induction. The mice were tested (no. of entries) until they made entries into all eight arms or until they completed 24 entries, whichever came first. Hence, the lower the score the better the cognitive function. Food and water were given at the completion of the test. Maze performance was calculated on each day for five consecutive days. Results are presented as area under the curve (AUC) utilizing the formula: (day 2 + day 3 + day 4 + day 5) -4*(day 1) (Pick and Yanai, 1983,) . Two independent observers who were blinded to sample identity performed all quantitative assessments. In cases where significant discrepancies were obvious between the two observers, the evaluation was repeated by a third one.
Brain histopathology and immunohistochemistry
Liver histopathology
Two days after the induction of hepatic failure, mice were killed by decapitation and their livers were excised and fixed in 4% neutral-buffered paraformaldehyde.
Liver histopathological analysis and scoring of necrosis (coagulative, centrilobular)
were performed as described previously (Avraham et al,2008a) .
Serum ammonia, liver enzymes and bilirubin levels
Serum for ALT, AST, bilirubin and ammonia measurements was obtained on day 3 in glass tubes, centrifuged, and analysed on the day of sampling using a Kone Progress Selective Chemistry Analyzer (Kone Instruments, Espoo, Finland). All serum samples were processed in the same laboratory using the same methods and the same reference values.
5-HT synthesis
On day 12, mice killed by decapitation and their brains were dissected out for determination of 5-HT levels. The assays for 5-HT were performed by standard alumina extraction, and HPLC with electrochemical detection using dehydroxybenzylamine (DHBA) as an internal standard (Avraham et al, 2006) .
Experimental design
Experiment 1 On the first day of this experiment, 20 mice were administered with TAA (200mg kg -1 ) and 20 saline. The following day, neurological evaluation was performed and saline-treated and TAA-treated mice were each assigned to two different sub-groups with approximately equal neurological score, which were administered either saline or CBD (5mg kg -1 ). On the third day, mice were evaluated for neurological and locomotor function, after which they were killed and their brains and livers were dissected out and fixed with 4% formaldehyde. Blood was drawn and separated for plasma, in which liver enzymes were quantified.
Experiment 2 This was identical to experiment 1 on days 1-3, only the mice were not killed on day 3 but were evaluated for cognitive function using the eight arm maze test, on days 8-12. On day 12, the mice were killed and their livers and brains were dissected out for determination of 5-HT levels.
Statistical analysis
All data are expressed as mean ±SEM. Statistical analysis was performed using oneway ANOVA followed by Bonferroni's post hoc test. P<0.05) and this was improved following CBD administration (P<0.01 vs TAA only).
Results
Neurological
CBD did not affect the cognitive function of control animals. Figure 4E, F) . However, the number of GFAP-positive cells mm -2 in TAA+5mg kg -1 CBD treated animals was reduced compared to TAA-treated animals ( Figure 4E ; Bonferroni: P=0.002). In contrast, CBD had no effect on the % of GFAP-positive surface in TAA animals ( Figure 4F ). Overall, it seems that TAA administration increased the number of activated astrocytes and CBD significantly reduced this effect. However, astrocytes in both CBD-and vehicle-treated TAA animals did not differ as regards their cellular size or extension of processes.
Brain and liver histopathology
TAA-treated animals showed the typical TAA-induced liver necrosis lesions that have been described in detail previously (Avraham et al,2008a) . The statistical analysis of liver histopathology scores did not reveal significant differences in the extent and severity of necrotic lesions between CBD-treated and untreated mice (data not shown).
5-HT levels
Whole brain 5-HT levels were increased by TAA administration ( Figure 5 ; ANOVA: 
Liver function
The levels of ammonia ( Figure 6A ), bilirubin ( Figure 6B ) and the liver enzymes AST ( Figure 6C ) and ALT ( Figure 6D ) were increased after TAA administration CBD did not affect the levels of any of these substances in control animals.
Discussion
Thioacetamide administration induces acute liver failure which leads to CNS changes related to those seen in HE (Zimmerman et al, 1989 , Avraham et al, 2006 2008a; 2009; Magen et al,2008) . The hepatotoxicity of TAA is due to the generation of free radicals and oxidative stress (Zimmerman et al, 1989) . However, it is not clear whether TAA affects the brain directly or the liver (Albrecht et al ., 1996) . In previous studies both a CB 1 antagonist and a CB 2 or TRPV1 agonist have been shown to ameliorate the brain and liver damage that occurs in liver disease and HE (Mallet and Lotersztajn,2008; Avraham et al,2006; 2008a,b; 2009 peripherally. In addition it has been shown that cannabidiol can cross the BBB and act centrally (for review see Pertwee ,2009) . Therefore, its effect may result from a combination of its actions in the liver and the brain. However, to elucidate its mechanism of action future experiments are needed to determine the effects of central administration of cannabidiol .
Previous work from our laboratory has demonstrated an impaired neurological and motor function 3 days, and impaired cognition 12 days after TAA injection to mice (Avraham et al, 2006; 2008a; 2009) . These results were reproduced in the present study (Figures 1-3) . In a more recent study from our laboratory, cognitive and motor deficits were observed 21 days after bile-duct ligation (BDL), a chronic model of liver disease (Magen et al, 2009a, b) . The different durations of the development of HE symptoms in the two models apparently result from their different characteristics -an acute vs a chronic model of HE. In the latter model, cannabidiol was found to improve cognition and locomotor activity, in accordance with our present data (Magen et al, 2009) . However, in sharp contrast to the findings reported here no evidence for astrogliosis was found in that study (data not reported); in our acute 14 model induced by TAA we observed astrogliosis after three days ( Figure 4C ). Those mice with histopathological alterations displayed an increased neurological score and decreased activity level, and 5mg kg -1 CBD reversed both the increase in the number of GFAP(+) cells, an index of neuroinflammation ( Figure 4E ), and the neurological and locomotor impairments (Figure 1 and 2) , suggesting a link between neuroinflammation and motor and neurological deficits. Similar results were reported by Jover et al.(2006) who demonstrated a decrease in motor activity in bile-duct ligated rats on a high-protein diet, in association with astrogliosis, and by Cauli et al(2009) , who reported that treatment with an anti-inflammatory restored the motor activity in HE. In the work of Jover et al. (2006) , astrogliosis was found only in the bile-duct ligated rats on a high protein diet, but not in the bile-duct ligated rats on a regular diet, similar to our previous findings (Avraham et al,2009) This suggests that TAA causes more severe damage to the brain than bile-duct ligation, and that hyperammonaemia is required to worsen the damage in BDL rats to an extent that is equivalent to that observed in TAA mice. The reason for this may be that in chronic liver disease induced by BDL, compensation mechanisms are activated, which moderate the brain damage, while in the acute model induced by TAA, no such mechanisms can come into action because of the severity of the liver insult and the short interval of time between the induction of liver damage and the histopathological examination. Kerfoot et al. (2006) showed the infiltration of peripheral monocytes into the brain of bile-duct ligated mice ten days after the ligation and suggested that this infiltration may cause the activation of inflammatory cells in the brain. Therefore, it is conceivable that such a mechanism was responsible for the astrogliosis observed in our study, since we found evidence of liver inflammation (data not shown). As evident from the histopathology results, cannabidiol did not appear to affect the development of TAA-induced necrotic lesions in the liver of mice. However, the levels of liver transaminases in the serum of cannabidiol-treated mice were significantly reduced compared to their untreated counterparts, indicating that this substance contributed to a partial restoration of liver function. Recent evidence elucidating the complicated mechanisms involved in the release of hepatocyte cytosolic enzymes such as ALT and AST in the blood may explain the discrepancy between histopathology and serum biochemistry data observed in the present study. Indeed, it is now generally accepted that the release of cytosolic enzymes during both the reversible and irreversible phases of hepatocyte injury and, therefore, their appearance in blood does not necessarily indicate cell death and also that enzyme release during reversible cell damage occurs with an apparent lack of histological evidence of necrosis (Solter, 2005) . Following this reasoning, it could be hypothesized that although cannabidiol did not reduce the levels of histologically detectable necrosis, it may have ameliorated the minute reversible hepatocyte damage that causes the so-called "leakage" of cytoplasmic ALT and AST in blood. The interaction between hyperammonaemia and inflammation as a precipitating factor for HE has been discussed in two recent reviews (Shawcross and Jalan ,2005 ; Wright and Jalan ,2007) . Further work is required to reveal the exact mechanism/s of the manner by which liver damage is related to dysfunction/damage in the brain, and studies using antagonists of the A 2A adenosine receptors, which are potential targets of cannabidiol that may mediate its anti-inflammatory effect (Carrier et al, 2006) , need to be carried out in order to elucidate the receptors involved in this effect.
Astrogliosis has also been shown to be involved in learning and memory deficits in a mouse model of Alzheimer's disease. In this study, astrogliosis was reduced by caloric restriction, which also reversed the cognitive deficits and increased the expression of neurogenesis in related genes (Wu et al, 2008) . Further studies, such as expression analysis of such genes using DNA microarray and evaluation of neurogenesis using BrdU staining, needs to be performed in order to explore the mechanisms through which TAA-induced astrogliosis impairs cognition, and through which cannabidiol acts to improve it.
Even though astrogliosis was found a week before cognitive function was observed, and it is not definite whether it was long-lasting, this mechanism seems, in our eyes, to account for the cognitive dysfunction, rather than the increase in 5-HT level ( Figure   5 ). The latter mechanism does not seem to be related to the cognitive dysfunction, even though this increase in 5-HT was reversed by CBD ( Figure 5 ), as 5-HT depletion, not increase, has been shown to cause memory deficits in the eight arm maze (Mazer et al., 1997) . On the other hand, there is much evidence that ammonia induces astrocyte swelling which via a number of mechanisms leads to impaired astrocyte/neuronal communication and synaptic plasticity, thereby resulting in a disturbance of oscillatory networks. The latter accounts for the symptoms of hepatic encephalopathy (for review see, Haussinger and Gorg, 2010) , among them presumably the cognitive dysfunction.
An increased level of 5-HT in the brain of rats after TAA administration was reported by Yurdaydin et al.(1990) . In addition, there is indirect evidence that this increase is related to decreased motor activity, as the nonselective 5-HT receptor antagonist methysergide increased motor activity in TAA-injected rats, while the selective 5-HT 2 receptor antagonist seganserin did not (Yurdaydin et al, 1996) . Likewise, we found that the level of 5-HT was increased following TAA administration and this was restored after cannabidiol treatment ( Figure 5 ). In parallel, motor activity was decreased following TAA injection and increased after cannabidiol treatment, indicating a link between the increase in 5-HT and decrease in motor activity. Hence, it seems that CBD reversed the increased 5-HT level in the brains of TAA mice and thus reversed the decrease in their motor activity. A possible mechanism can be activation of 5-HT 1A receptors by CBD (Russo et al, 2005) , as these receptors have been reported to inhibit 5-HT synthesis (Invernizzi et al,1991) . We have shown that the effects of cannabidiol in a chronic model of HE, bile duct ligation, are mediated via the 5-HT 1A receptors (Magen et al., 2010) and in an earlier study with the same model we demonstrated that the effects of cannabidiol can be also mediated via A 2A adenosine receptors (Magen et al., 2009) . Thus, the effects of cannabidiol, can be mediated by 5-HT 1A or/and A 2A adenosine receptors. We think that in the current study the effects of cannabidiol were mediated by the 5-HT 1A receptor since activation of the receptor by cannabidiol caused depletion of 5-HT ( Figure 5 ). In our previous studies we showed that cognition is multifactorial and not dependent only on 5-HT levels, therefore there is no direct correlation between cognition and 5-HT levels.
The reversal of astrogliosis was probably related to reduced hepatic toxin formation. Indeed, there is much evidence that ammonia induces astrocyte swelling, which via a number of mechanisms leads to impaired astrocyte/neuronal communication and synaptic plasticity, thereby resulting in a disturbance of oscillatory networks. The latter accounts for the symptoms of hepatic encephalopathy (for review see, Haussinger and Gorg, 2010) , among them presumably the cognitive dysfunction.
Neurological and motor functions were improved two and three days, respectively, after induction of hepatic failure at the same time as a partial reversal of the astrogliosis and reduced levels of ammonia, bilirubin and liver enzymes were noticed. It seems that the behavioural effects of cannabidiol are dramatic and occur within 3 days.
In summary, the present study demonstrates the therapeutic effects of CBD in an acute model of HE. It appears that this effect of CBD is multi-factorial and involves cannabinoid (Avraham et al, 2006) , vanilloid (Avraham et al, 2008a; 2009) and 5-HT 1A receptors (Magen et al,2009b) . CBD improves the symptoms of FHF by affecting both brain histopathology and liver function, and thus may serve as therapeutic agent for treating human HE. 5mg kg -1 CBD had no effect on the GFAP-positive surface in the brains of TAAtreated mice. ***P<0.001 vs. control. Scale bars: 100μm. and ALT (D) were all increased in the plasma of TAA mice and were all reversed by CBD. **P<0.01 vs control, #P<0.01 vs TAA.
